Product & Pipeline Enhancement for Generics 2015

The 8th Product & Pipeline Enhancement for Generics conference will bring together generic pharmaceutical professionals who handle portfolio and project management, regulatory affairs, andbusiness development to discuss key issues surrounding new FDA regulations, GDUFA initiatives, current R&D trends, programs, biosimilars, portfolio diversification, resource allocation, outsourcing, intellectual property issues, Inter Partes Reviews (IPRs) and company consolidations impacting the portfolio. This meeting will feature two full days of interactive case study presentations, networking opportunities and Q&A time with leading practitioners in the industry. Seating is limited to maintain an intimate educational environment that will cultivate the knowledge and experience of all participants in attendance.